BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 2664950)

  • 1. 32P-postlabeling assay for carcinogen-DNA adducts and other dna modifications.
    Randerath K; Randerath E
    J UOEH; 1989 Mar; 11 Suppl():368-86. PubMed ID: 2664950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring carcinogen actions on DNA by 32P-postlabeling.
    Randerath K; Randerath E
    Princess Takamatsu Symp; 1990; 21():317-28. PubMed ID: 2134685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exogenous and endogenous DNA modifications as monitored by 32P-postlabeling: relationships to cancer and aging.
    Randerath K; Li D; Nath R; Randerath E
    Exp Gerontol; 1992; 27(5-6):533-49. PubMed ID: 1426086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of the 32P-postlabelling assay to study transplacental carcinogens and transplacental carcinogenesis.
    Randerath K; Liehr JG; Gladek A; Randerath E
    IARC Sci Publ; 1989; (96):189-205. PubMed ID: 2509347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclease P1-mediated enhancement of sensitivity of 32P-postlabeling test for structurally diverse DNA adducts.
    Reddy MV; Randerath K
    Carcinogenesis; 1986 Sep; 7(9):1543-51. PubMed ID: 3017601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of HPLC in the 32P-postlabeling assay.
    Gorelick NJ
    Mutat Res; 1993 Jul; 288(1):5-18. PubMed ID: 7686266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative 32P-analysis of cigarette smoke-induced DNA damage in human tissues and mouse skin.
    Randerath E; Avitts TA; Reddy MV; Miller RH; Everson RB; Randerath K
    Cancer Res; 1986 Nov; 46(11):5869-77. PubMed ID: 3756927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced sensitivity of 32P-postlabeling analysis of aromatic carcinogen:DNA adducts.
    Gupta RC
    Cancer Res; 1985 Nov; 45(11 Pt 2):5656-62. PubMed ID: 4053037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of polycyclic aromatic hydrocarbon-DNA adducts in white blood cells from coke oven workers: correlation with job categories.
    Ovrebø S; Haugen A; Phillips DH; Hewer A
    Cancer Res; 1992 Mar; 52(6):1510-4. PubMed ID: 1540959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-performance liquid chromatographic analysis of 32P-postlabeled DNA-aromatic carcinogen adducts.
    Levy GN; Weber WW
    Anal Biochem; 1988 Nov; 174(2):381-92. PubMed ID: 3239743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 32P-postlabeling assay for carcinogen-DNA adducts: nuclease P1-mediated enhancement of its sensitivity and applications.
    Reddy MV; Randerath K
    Environ Health Perspect; 1987 Dec; 76():41-7. PubMed ID: 2834194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postlabeling methods for carcinogen-DNA adduct analysis.
    Randerath K; Randerath E; Agrawal HP; Gupta RC; Schurdak ME; Reddy MV
    Environ Health Perspect; 1985 Oct; 62():57-65. PubMed ID: 3910421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 32P-postlabeling analysis of DNA adducts in tissues of rats exposed to coke-oven emissions.
    Binková B; Dobiás L; Wolff T; Srám RJ
    Mutat Res; 1994 May; 307(1):355-63. PubMed ID: 7513816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aromatic DNA adducts in white blood cells of foundry workers.
    Hemminki K; Perera FP; Phillips DH; Randerath K; Reddy MV; Santella RM
    IARC Sci Publ; 1988; (89):190-5. PubMed ID: 3143668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of 32P-postlabeling analysis of DNA from exfoliated oral mucosa cells as a means of monitoring exposure of the oral cavity to genotoxic agents.
    Foiles PG; Miglietta LM; Quart AM; Quart E; Kabat GC; Hecht SS
    Carcinogenesis; 1989 Aug; 10(8):1429-34. PubMed ID: 2502322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 32P-postlabeling test for covalent DNA binding of chemicals in vivo: application to a variety of aromatic carcinogens and methylating agents.
    Reddy MV; Gupta RC; Randerath E; Randerath K
    Carcinogenesis; 1984 Feb; 5(2):231-43. PubMed ID: 6697441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of carcinogen-DNA adducts in exfoliated urothelial cells of cigarette smokers: association with smoking, hemoglobin adducts, and urinary mutagenicity.
    Talaska G; Schamer M; Skipper P; Tannenbaum S; Caporaso N; Unruh L; Kadlubar FF; Bartsch H; Malaveille C; Vineis P
    Cancer Epidemiol Biomarkers Prev; 1991; 1(1):61-6. PubMed ID: 1845172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical (postlabelling) methods for analysis of carcinogen-DNA adducts.
    Randerath K; Randerath E; Agrawal HP; Reddy MV
    IARC Sci Publ; 1984; (59):217-31. PubMed ID: 6443609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring occupational exposure to carcinogens: detection by 32P-postlabelling of aromatic DNA adducts in white blood cells from iron foundry workers.
    Phillips DH; Hemminki K; Alhonen A; Hewer A; Grover PL
    Mutat Res; 1988 Mar; 204(3):531-41. PubMed ID: 3347220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined micropreparative techniques with synchronous fluorescence spectroscopy or 32P-postlabelling assay for carcinogen-DNA adduct determination.
    Shields PG; Kato S; Bowman ED; Petruzzelli S; Cooper DP; Povey AC; Weston A
    IARC Sci Publ; 1993; (124):243-54. PubMed ID: 8225491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.